Our top pick for
Building a portfolio
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy CryoLife stock
Own CryoLife stock in just a few minutes.
CryoLife, Inc is a medical devices business based in the US. CryoLife shares (CRY) are listed on the NYSE and all prices are listed in US Dollars. CryoLife employs 1,200 staff and has a trailing 12-month revenue of around USD$253.2 million.
How to buy shares in CryoLife
- Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
- Search for CryoLife. Find the stock by name or ticker symbol: CRY. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until CryoLife reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of CryoLife, depending on your broker.
- Check in on your investment. Congratulations, you own a part of CryoLife. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
What's in this guide?
CryoLife share price
Use our graph to track the performance of CRY stocks over time.CryoLife shares at a glance
Information last updated 2021-04-08.
| 52-week range | USD$16.13 - USD$26.6 |
|---|---|
| 50-day moving average | USD$24.026 |
| 200-day moving average | USD$22.0912 |
| Wall St. target price | USD$30.92 |
| PE ratio | 504 |
| Dividend yield | USD$0.03 (0.13%) |
| Earnings per share (TTM) | USD$0.044 |
Buy CryoLife shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy CryoLife stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Is CryoLife under- or over-valued?
Valuing CryoLife stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of CryoLife's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
CryoLife's P/E ratio
CryoLife's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 504x. In other words, CryoLife shares trade at around 504x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
CryoLife's PEG ratio
CryoLife's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 420.8333. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into CryoLife's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
CryoLife's EBITDA
CryoLife's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$27.7 million.
The EBITDA is a measure of a CryoLife's overall financial performance and is widely used to measure a its profitability.
CryoLife financials
| Revenue TTM | USD$253.2 million |
|---|---|
| Operating margin TTM | 2.75% |
| Gross profit TTM | USD$167.8 million |
| Return on assets TTM | 0.62% |
| Return on equity TTM | -5.43% |
| Profit margin | -6.59% |
| Book value | $8.449 |
| Market capitalisation | USD$867.3 million |
TTM: trailing 12 months
Shorting CryoLife shares
There are currently 3.7 million CryoLife shares held short by investors – that's known as CryoLife's "short interest". This figure is 1.3% down from 3.8 million last month.
There are a few different ways that this level of interest in shorting CryoLife shares can be evaluated.
CryoLife's "short interest ratio" (SIR)
CryoLife's "short interest ratio" (SIR) is the quantity of CryoLife shares currently shorted divided by the average quantity of CryoLife shares traded daily (recently around 164372.96703297). CryoLife's SIR currently stands at 22.75. In other words for every 100,000 CryoLife shares traded daily on the market, roughly 22750 shares are currently held short.
However CryoLife's short interest can also be evaluated against the total number of CryoLife shares, or, against the total number of tradable CryoLife shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case CryoLife's short interest could be expressed as 0.1% of the outstanding shares (for every 100,000 CryoLife shares in existence, roughly 100 shares are currently held short) or 0.1211% of the tradable shares (for every 100,000 tradable CryoLife shares, roughly 121 shares are currently held short).
A SIR above 20% would generally be considered very high, pointing to a pessimistic outlook for the share price, with a discouraging number of investors currently willing to bet against CryoLife.
Find out more about how you can short CryoLife stock.
CryoLife share dividends
We're not expecting CryoLife to pay a dividend over the next 12 months.
Have CryoLife's shares ever split?
CryoLife's shares were split on a 3:2 basis on 27 December 2000. So if you had owned 2 shares the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your CryoLife shares – just the quantity. However, indirectly, the new 33.3% lower share price could have impacted the market appetite for CryoLife shares which in turn could have impacted CryoLife's share price.
CryoLife share price volatility
Over the last 12 months, CryoLife's shares have ranged in value from as little as $16.13 up to $26.6. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while CryoLife's is 1.4672. This would suggest that CryoLife's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
CryoLife overview
CryoLife, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. It offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, pulmonary, and general surgical applications; On-X prosthetic aortic and mitral heart valve, and On-X ascending aortic prosthesis; cardiac preservation services; PhotoFix, a bovine pericardial patch; and E-vita OPEN PLUS and E-vita OPEN NEO, a hybrid stent graft system. The company also provides E-xtra DESIGN ENGINEERING products for the treatment of aortic vascular diseases; E-nside, an off-the-shelf stent graft for the treatment of thoraco-abdominal disease; E-vita THORACIC 3G for the endovascular treatment of thoracic aortic aneurysms; E-nya, a thoracic stent graft system for the minimally invasive repair of lesions of the descending aorta; E-ventus BX, a balloon-expandable peripheral stent graft for the endovascular treatment of renal and pelvic arteries; E-liac to treat aneurysmal iliac arteries, and aneurysmal iliac side branches; and E-tegra, an abdominal aortic aneurysms stent graft system. In addition, it offers synthetic vascular grafts for use in open aortic and peripheral vascular surgical procedures; PerClot, an absorbable powdered hemostat for use in surgical procedures; and cardiac laser therapy products, such as SolarGen 2100s Console and SoloGrip III disposable handpieces. Further, the company sells CryoVein femoral vein and CryoArtery femoral artery vascular preservation services; CarbonAid CO2 diffusion catheters and Chord-X ePTFE sutures for mitral chordal replacement; and ascyrus medical dissection stents, as well as offers pyrolytic carbon coating services to other medical device manufacturers. The company serves physicians, hospitals, and other healthcare facilities, as well as cardiac, vascular, thoracic, and general surgeons. CryoLife, Inc. was founded in 1984 and is headquartered in Kennesaw, Georgia.
Frequently asked questions
More guides on Finder
-
How to buy Sigma Labs stock
Steps to owning and managing SGLB, with 24-hour and historical pricing before you buy.
-
How to buy Simpson Manufacturing CoInc stock
Steps to owning and managing SSD, with 24-hour and historical pricing before you buy.
-
How to buy Sequans Communications S-A stock
Steps to owning and managing SQNS, with 24-hour and historical pricing before you buy.
-
How to buy SFL Corporation stock
Steps to owning and managing SFL, with 24-hour and historical pricing before you buy.
-
How to buy Senmiao Technology stock
Steps to owning and managing AIHS, with 24-hour and historical pricing before you buy.
-
How to buy Sensata Technologies Holding stock
Steps to owning and managing ST, with 24-hour and historical pricing before you buy.
-
How to buy Select Bancorp stock
Steps to owning and managing SLCT, with 24-hour and historical pricing before you buy.
-
How to buy Second Sight Medical Products stock
Steps to owning and managing EYES, with 24-hour and historical pricing before you buy.
-
How to buy Sibanye Stillwater stock
Steps to owning and managing SBSW, with 24-hour and historical pricing before you buy.
-
How to buy Shinhan Financial Group CoLtd stock
Steps to owning and managing SHG, with 24-hour and historical pricing before you buy.
Ask an Expert